P318 Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjab232.445
Abstract: There was a significant progress in the medical therapy of inflammatory bowel diseases(IBD) with the advent of biological compounds, yet patients may experience adverse events(AE): infusion/injection reactions, infections and malignancies, understudied in vulnerable patient populations… read more here.
Keywords: elderly ibd; safety; meta analysis; therapies elderly ... See more keywords
Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma—A population‐based study from Sweden
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13090
Abstract: Forty percent of Hodgkin lymphoma (HL) patients are older than 50 years at diagnosis, a fact which is not commonly recognized. Older patients do significantly worse than younger patients and are rarely included in clinical… read more here.
Keywords: developing therapies; paid developing; hodgkin lymphoma; greater attention ... See more keywords